APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyzine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hydroxyzine Market Outlook and Growth Opportunities 2026

Report ID 174000850427 December 2025190 pages

Choose your research edition.

Industry ResearchHydroxyzine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyzine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hydroxyzine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyzine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyzine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hydroxyzine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hydroxyzine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hydroxyzine market include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxyzine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxyzine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyzine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyzine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyzine Segment by Company

GSK

Impax Laboratories

N&R Industries

Novartis

Pfizer

Piramal Group (Piramal Healthcare UK Limited)

Shanghai Ruizheng Chemical Technology

Teva Pharmaceuticals

Alliance Pharma

Hydroxyzine Segment by Type

Tablets

Capsules

Other

Hydroxyzine Segment by Application

Hospitals

Retail Pharmacy

Hydroxyzine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hydroxyzine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hydroxyzine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hydroxyzine significant trends, drivers, influence factors in global and regions.

6. To analyze Hydroxyzine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyzine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hydroxyzine industry.

Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hydroxyzine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hydroxyzine Industry Trends Table 2. Hydroxyzine Industry Drivers Table 3. Hydroxyzine Industry Opportunities and Challenges Table 4. Hydroxyzine Industry Restraints Table 5. Global Hydroxyzine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hydroxyzine Revenue Share by Company (2021-2026) Table 7. Global Hydroxyzine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hydroxyzine Sales Volume Share by Company (2021-2026) Table 9. Global Hydroxyzine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Hydroxyzine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hydroxyzine Key Company Manufacturing Base & Headquarters Table 12. Global Hydroxyzine Company, Product Type & Application Table 13. Global Hydroxyzine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyzine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Significant Companies of Other Table 20. Global Hydroxyzine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Hydroxyzine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Hydroxyzine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Hydroxyzine Sales Volume Share by Type (2021-2026) Table 24. Global Hydroxyzine Sales Volume Share by Type (2027-2032) Table 25. Global Hydroxyzine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hydroxyzine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Hydroxyzine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Hydroxyzine Sales Value Share by Type (2021-2026) Table 29. Global Hydroxyzine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Retail Pharmacy Table 32. Global Hydroxyzine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Hydroxyzine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Hydroxyzine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Hydroxyzine Sales Volume Share by Application (2021-2026) Table 36. Global Hydroxyzine Sales Volume Share by Application (2027-2032) Table 37. Global Hydroxyzine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Hydroxyzine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Hydroxyzine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Hydroxyzine Sales Value Share by Application (2021-2026) Table 41. Global Hydroxyzine Sales Value Share by Application (2027-2032) Table 42. Global Hydroxyzine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Hydroxyzine Sales by Region (2021-2026) & (K Units) Table 44. Global Hydroxyzine Sales Market Share by Region (2021-2026) Table 45. Global Hydroxyzine Sales by Region (2027-2032) & (K Units) Table 46. Global Hydroxyzine Sales Market Share by Region (2027-2032) Table 47. Global Hydroxyzine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Hydroxyzine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Hydroxyzine Sales Value Share by Region (2021-2026) Table 50. Global Hydroxyzine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Hydroxyzine Sales Value Share by Region (2027-2032) Table 52. Global Hydroxyzine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Hydroxyzine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Hydroxyzine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 57. Global Hydroxyzine Sales Market Share by Country (2021-2026) Table 58. Global Hydroxyzine Sales by Country (2027-2032) & (K Units) Table 59. Global Hydroxyzine Sales Market Share by Country (2027-2032) Table 60. Global Hydroxyzine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Hydroxyzine Sales Value Market Share by Country (2021-2026) Table 62. Global Hydroxyzine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Hydroxyzine Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Hydroxyzine Product Portfolio Table 68. GSK Recent Development Table 69. Impax Laboratories Company Information Table 70. Impax Laboratories Business Overview Table 71. Impax Laboratories Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Impax Laboratories Hydroxyzine Product Portfolio Table 73. Impax Laboratories Recent Development Table 74. N&R Industries Company Information Table 75. N&R Industries Business Overview Table 76. N&R Industries Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. N&R Industries Hydroxyzine Product Portfolio Table 78. N&R Industries Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Novartis Hydroxyzine Product Portfolio Table 83. Novartis Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pfizer Hydroxyzine Product Portfolio Table 88. Pfizer Recent Development Table 89. Piramal Group (Piramal Healthcare UK Limited) Company Information Table 90. Piramal Group (Piramal Healthcare UK Limited) Business Overview Table 91. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio Table 93. Piramal Group (Piramal Healthcare UK Limited) Recent Development Table 94. Shanghai Ruizheng Chemical Technology Company Information Table 95. Shanghai Ruizheng Chemical Technology Business Overview Table 96. Shanghai Ruizheng Chemical Technology Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio Table 98. Shanghai Ruizheng Chemical Technology Recent Development Table 99. Teva Pharmaceuticals Company Information Table 100. Teva Pharmaceuticals Business Overview Table 101. Teva Pharmaceuticals Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Teva Pharmaceuticals Hydroxyzine Product Portfolio Table 103. Teva Pharmaceuticals Recent Development Table 104. Alliance Pharma Company Information Table 105. Alliance Pharma Business Overview Table 106. Alliance Pharma Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Alliance Pharma Hydroxyzine Product Portfolio Table 108. Alliance Pharma Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Hydroxyzine Distributors List Table 112. Hydroxyzine Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Hydroxyzine Product Image Figure 2. Global Hydroxyzine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hydroxyzine Sales (2021-2032) & (K Units) Figure 5. Global Hydroxyzine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Hydroxyzine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Other Image Figure 12. Global Hydroxyzine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Hydroxyzine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Hydroxyzine Sales Volume Share by Type (2021-2032) Figure 15. Global Hydroxyzine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Hydroxyzine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Hydroxyzine Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Retail Pharmacy Image Figure 20. Global Hydroxyzine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Hydroxyzine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Hydroxyzine Sales Volume Share by Application (2021-2032) Figure 23. Global Hydroxyzine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Hydroxyzine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Hydroxyzine Sales Value Share by Application (2021-2032) Figure 26. Global Hydroxyzine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Hydroxyzine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Hydroxyzine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Hydroxyzine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Hydroxyzine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Hydroxyzine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Hydroxyzine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Hydroxyzine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Hydroxyzine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Hydroxyzine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Hydroxyzine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Hydroxyzine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Hydroxyzine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Hydroxyzine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Hydroxyzine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
  • Other
Applications
  • Hospitals
  • Retail Pharmacy
Companies covered
  • GSK
  • Impax Laboratories
  • N&R Industries
  • Novartis
  • Pfizer
  • Piramal Group (Piramal Healthcare UK Limited)
  • Shanghai Ruizheng Chemical Technology
  • Teva Pharmaceuticals
  • Alliance Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxyzine Sales Value (2021-2032)
  4. 1.2.2 Global Hydroxyzine Sales Volume (2021-2032)
  5. 1.2.3 Global Hydroxyzine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hydroxyzine Market Dynamics
  1. 2.1 Hydroxyzine Industry Trends
  2. 2.2 Hydroxyzine Industry Drivers
  3. 2.3 Hydroxyzine Industry Opportunities and Challenges
  4. 2.4 Hydroxyzine Industry Restraints
3 Hydroxyzine Market by Company
  1. 3.1 Global Hydroxyzine Company Revenue Ranking in 2025
  2. 3.2 Global Hydroxyzine Revenue by Company (2021-2026)
  3. 3.3 Global Hydroxyzine Sales Volume by Company (2021-2026)
  4. 3.4 Global Hydroxyzine Average Price by Company (2021-2026)
  5. 3.5 Global Hydroxyzine Company Ranking (2024-2026)
  6. 3.6 Global Hydroxyzine Company Manufacturing Base and Headquarters
  7. 3.7 Global Hydroxyzine Company Product Type and Application
  8. 3.8 Global Hydroxyzine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hydroxyzine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hydroxyzine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hydroxyzine Market by Type
  1. 4.1 Hydroxyzine Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.1.3 Other
  5. 4.2 Global Hydroxyzine Sales Volume by Type
  6. 4.2.1 Global Hydroxyzine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hydroxyzine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Hydroxyzine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Hydroxyzine Sales Value by Type
  10. 4.3.1 Global Hydroxyzine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hydroxyzine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Hydroxyzine Sales Value Share by Type (2021-2032)
5 Hydroxyzine Market by Application
  1. 5.1 Hydroxyzine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Hydroxyzine Sales Volume by Application
  5. 5.2.1 Global Hydroxyzine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyzine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Hydroxyzine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Hydroxyzine Sales Value by Application
  9. 5.3.1 Global Hydroxyzine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyzine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Hydroxyzine Sales Value Share by Application (2021-2032)
6 Hydroxyzine Regional Sales and Value Analysis
  1. 6.1 Global Hydroxyzine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyzine Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyzine Sales by Region: 2021-2026
  4. 6.2.2 Global Hydroxyzine Sales by Region (2027-2032)
  5. 6.3 Global Hydroxyzine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hydroxyzine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hydroxyzine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hydroxyzine Sales Value by Region (2027-2032)
  9. 6.5 Global Hydroxyzine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hydroxyzine Sales Value (2021-2032)
  12. 6.6.2 North America Hydroxyzine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hydroxyzine Sales Value (2021-2032)
  15. 6.7.2 Europe Hydroxyzine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hydroxyzine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hydroxyzine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hydroxyzine Sales Value (2021-2032)
  21. 6.9.2 South America Hydroxyzine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hydroxyzine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hydroxyzine Sales Value Share by Country, 2025 VS 2032
7 Hydroxyzine Country-level Sales and Value Analysis
  1. 7.1 Global Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hydroxyzine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hydroxyzine Sales by Country (2021-2032)
  4. 7.3.1 Global Hydroxyzine Sales by Country (2021-2026)
  5. 7.3.2 Global Hydroxyzine Sales by Country (2027-2032)
  6. 7.4 Global Hydroxyzine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hydroxyzine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hydroxyzine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hydroxyzine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hydroxyzine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hydroxyzine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hydroxyzine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hydroxyzine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hydroxyzine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hydroxyzine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hydroxyzine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hydroxyzine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hydroxyzine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hydroxyzine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hydroxyzine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hydroxyzine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hydroxyzine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hydroxyzine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hydroxyzine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hydroxyzine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hydroxyzine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hydroxyzine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hydroxyzine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hydroxyzine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hydroxyzine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hydroxyzine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hydroxyzine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hydroxyzine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hydroxyzine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hydroxyzine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hydroxyzine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hydroxyzine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hydroxyzine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hydroxyzine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Hydroxyzine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Impax Laboratories
  8. 8.2.1 Impax Laboratories Company Information
  9. 8.2.2 Impax Laboratories Business Overview
  10. 8.2.3 Impax Laboratories Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Impax Laboratories Hydroxyzine Product Portfolio
  12. 8.2.5 Impax Laboratories Recent Developments
  13. 8.3 N&R Industries
  14. 8.3.1 N&R Industries Company Information
  15. 8.3.2 N&R Industries Business Overview
  16. 8.3.3 N&R Industries Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 N&R Industries Hydroxyzine Product Portfolio
  18. 8.3.5 N&R Industries Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Hydroxyzine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Hydroxyzine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Piramal Group (Piramal Healthcare UK Limited)
  32. 8.6.1 Piramal Group (Piramal Healthcare UK Limited) Company Information
  33. 8.6.2 Piramal Group (Piramal Healthcare UK Limited) Business Overview
  34. 8.6.3 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio
  36. 8.6.5 Piramal Group (Piramal Healthcare UK Limited) Recent Developments
  37. 8.7 Shanghai Ruizheng Chemical Technology
  38. 8.7.1 Shanghai Ruizheng Chemical Technology Company Information
  39. 8.7.2 Shanghai Ruizheng Chemical Technology Business Overview
  40. 8.7.3 Shanghai Ruizheng Chemical Technology Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio
  42. 8.7.5 Shanghai Ruizheng Chemical Technology Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Hydroxyzine Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Alliance Pharma
  50. 8.9.1 Alliance Pharma Company Information
  51. 8.9.2 Alliance Pharma Business Overview
  52. 8.9.3 Alliance Pharma Hydroxyzine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alliance Pharma Hydroxyzine Product Portfolio
  54. 8.9.5 Alliance Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyzine Value Chain Analysis
  2. 9.1.1 Hydroxyzine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyzine Sales Mode & Process
  6. 9.2 Hydroxyzine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyzine Distributors
  9. 9.2.3 Hydroxyzine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst